Is this your company?
Claim this profile to get matched with investors who fund Health startups in United Kingdom.
Claim this profile →🏆 Featured in Datapile’s Q4 2026 UK Funding Report
Read the Q4 2026 UK report →Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-uk-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile’s Q4 2026 UK Funding Report</a>Funding history
- 2
- 1€275 millionOct 16, 2026Announcement ↗
Investors in OMass Therapeutics
Backers from this company's tracked funding rounds.
- BBain Capital Life SciencesLead investorVC firm
- FForbionVC firm
- NNovo HoldingsVC firm
- JJanus Henderson InvestorsVC firm
- SSV Health InvestorsVC firm
- JJefferson Life SciencesVC firm
- SSynconaVC firm
- OOxford Science EnterprisesVC firm
OMass Therapeutics in the news
Coverage of this company's funding, tracked by Datapile.
- Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder ↗MedCity News · Oct 18, 2026
- Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients ↗EU-Startups · Oct 16, 2026
More Health companies
Recently funded startups in the same category.